The University of British Columbia
The University of British Columbia's Perrin Laboratory is seeking a highly motivated DNA/Aptamer Chemist to join a multidisciplinary research team developing nucleic acid-based targeting agents for prostate cancer treatment. The role focuses on the design, synthesis, modification, and biophysical characterization of DNA aptamers to create translational cancer research solutions. This position is ideal for a chemist or chemical biologist interested in applying nucleic acid chemistry to therapeutic development.
The University of British Columbia is a global centre for research and teaching, consistently ranked among the top 20 public universities in the world.
Alloy Therapeutics and University of British Columbia Partner to Accelerate Antibody Discovery with Cryo-Electron Microscopy Technology
Oct 7, 2025
B.C.'s biggest ski resort offers discounts for people aged 13 to 30
3 days ago
BRITISH COLUMBIA MOVERS & SHAKERS FEBRUARY 27, 2026
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for The University of British Columbia.
Alexandre Corhay Rotman School of Management University of Toronto
Dec 1, 2025
PhD Student in Aptamer-Enabled, Animal-Free Bioanalysis
Novo Nordisk A/S
Research Fellow
Oracle
Sr. Scientist/Staff Scientist: Nucleotide and Nucleic Acid Chemistry
Atlas Data Storage
Senior Scientist Chemistry (m/f/d) in Chemistry R&D Diagnostics with focus on Oligonucleotide synthesis
Roche
Research Associate I
UMass Chan Medical School
Scientist
Serif